Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628787 | 0.90 | OPRM1 (0.51) | OPRM1OPRK1HDAC6HDAC1TAS1R3 | |
| SCHEMBL21628696 | 0.90 | PLK1 (0.56) | OPRM1OPRK1TAS1R3TAS1R1 | |
| SCHEMBL21628778 | 0.88 | SMPD1 (0.54) | OPRM1OPRK1HDAC6HDAC1HDAC3 | |
| SCHEMBL21628860 | 0.87 | SMPD1 (0.58) | OPRM1OPRK1SMPD1 | |
| SCHEMBL21628662 | 0.86 | KMT2A (0.48) | — | |
| SCHEMBL21628733 | 0.86 | SMPD1 (0.60) | SMPD1 | |
| SCHEMBL21628451 | 0.85 | HDAC1 (0.56) | OPRM1OPRK1HDAC6HDAC1HDAC8 | |
| SCHEMBL21628551 | 0.85 | LMNA (0.56) | — | |
| SCHEMBL21628562 | 0.84 | PARP10 (0.55) | OPRM1OPRK1 | |
| SCHEMBL29921049 | 0.82 | HDAC6 (0.49) | OPRM1OPRK1HDAC6HDAC1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRM1 3978/4885OPRK1 2780/4885HDAC6 2604/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRM1 3978/4885OPRK1 2780/4885HDAC6 2604/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | OPRM1 4075/4885OPRK1 3124/4885HDAC6 2978/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | OPRM1 817/4885OPRK1 684/4885HDAC6 1293/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRM1 3978/4885OPRK1 2780/4885HDAC6 2604/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRM1 3978/4885OPRK1 2780/4885HDAC6 2604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.